 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sequent Scienti Consolidated September 2023 Net Sales at Rs 345.97 crore, up 2.48% Y-o-Y

Sequent Scienti Standalone September 2023 Net Sales at Rs 49.12 crore, down 9.43% Y-o-Y

The board approved saletransfer of the companys API facility situated at Plot Nos. 136, 137, 138, 139, 140, 141, 150, 151 & W&#8208;152, MIDC, Tarapur, Boisar Dist. Thane, Maharashtra &#8208; 401506, India.The board also announced a notice of postal ballot seeking shareholders approval for the proposed saletransfer of the API facility.  Secondly, Grant Thornton Bharat was appointed as the companys internal auditors. Sequent Scientific is a global pharmaceutical company specializing in Animal Health. With a strong international presence, the company operates in both API and formulation domains. Their focus lies in addressing unmet market needs for livestock, poultry, and companion animals.  Sequent Scientific reported net loss of Rs 34.85 crore in Q1 June 2023, higher than net loss of Rs 14.97 crore in Q1 June 2022. Net sales declined 2.38% YoY to Rs 333.21 crore in Q1 June 2023. 

Sequent Scientific jumps after board approves API facility sale

Sequent Scientific is involved in the animal health business working on veterinary active pharmaceutical ingredients and formulations.

Sequent Scientific zooms 9% as board approves sale of Thane API facility

Sequent Scienti Consolidated June 2023 Net Sales at Rs 333.21 crore, down 2.38% Y-o-Y

Revenue from operations slipped 2.3 percent to Rs 333.2 crore in the first quarter of FY24 compared to Rs 341.3 crore in the year-ago period.

Sequent Scientific slumps 6% after Q1 loss widens to Rs 34.7 cr

Sequent Scienti Consolidated March 2023 Net Sales at Rs 366.67 crore, down 4.44% Y-o-Y

The animal health company posted a net loss of Rs 92.43 crore for the quarter ended March.

SeQuent Scientific dips 2% after Q4 loss

Sequent Scienti Standalone March 2023 Net Sales at Rs 46.60 crore, down 26.82% Y-o-Y

Sequent Scienti Standalone December 2022 Net Sales at Rs 57.00 crore, down 3.7% Y-o-Y

SeQuent Scientific Ltd. engages in the manufacturing and development of veterinary pharmaceuticals and specialty chemicals. It operates through the following geographical segments: Europe, Asia, and Rest of the World. The company was founded on June 28, 1985 and is headquartered in Mumbai, India.

Market Cap	29.25B
Volume (M)	446,784.00
52-Wk High	128.70
52-Wk Low	61.80

SEQUENT.NSE Sequent Scientific Ltd

About

Feed

News

Fundamentals